scholarly journals Management of radiation-induced nausea and vomiting with palonosetron in patients with pre-existing emesis: a pilot study

2018 ◽  
Vol 7 (4) ◽  
pp. 385-392 ◽  
Author(s):  
Vithusha Ganesh ◽  
Stephanie Chan ◽  
Liying Zhang ◽  
Leah Drost ◽  
Carlo DeAngelis ◽  
...  
Keyword(s):  
Pilot Study ◽  
Nausea And Vomiting ◽  
Radiation Induced

A pilot study with palonosetron in the prophylaxis of radiation-induced nausea and vomiting

2018 ◽  
Vol 7 (2) ◽  
pp. 211-220 ◽  
Author(s):  
Vithusha Ganesh ◽  
Leah Drost ◽  
Carlo DeAngelis ◽  
Bo Angela Wan ◽  
Mark Pasetka ◽  
...  
Keyword(s):  
Pilot Study ◽  
Nausea And Vomiting ◽  
Radiation Induced

A review on radiation induced nausea and vomiting: “Current management strategies and prominence of radio sensitizers”

2021 ◽  
pp. 107815522110115
Author(s):  
Meenu Vijayan ◽  
Sherin Joseph ◽  
Emmanuel James ◽  
Debnarayan Dutta
Keyword(s):  
Radiation Therapy ◽  
Cell Damage ◽  
Genetic Material ◽  
High Energy ◽  
Concurrent Chemotherapy ◽  
Nausea And Vomiting ◽  
Dose Fractionation ◽  
Psychological State ◽  
Related Factors ◽  
Radiation Induced

Radiations dissipated are high energy waves used mostly as treatment intervention in controlling the unwanted multiplication of cell. About 60%–65% of cancer treatment requires radiation therapy and 40%–80% of radiation therapy causes RINV which are true troublemakers. Radiation therapy (RT) is targeted therapy mostly used to treat early stages of tumour and prevent their reoccurrence. They mainly destroy the genetic material (DNA) of cancerous cells to avoid their unwanted growth and division. The RINV affects the management and quality of life of patients which further reduces the patient outcome. RINV depends on RT related factors (dose, fractionation, irradiation volume, RT techniques) and patient related factors like (gender, health conditions, age, concurrent chemotherapy, psychological state, and tumour stage). RT is an active area of research and there is only limited progress in tackling the RINV crisis. Advanced technological methods are adopted that led to better understanding of total lethal doses. Radiation therapy also affects the immunity system that leads to radiation induced immune responses and inflammation. Radio sensitizers are used to sensitize the tumour cells to radiations that further prevent the normal cell damage from radiation exposure. There is a need for future studies and researches to re-evaluate the data available from previous trials in RINV to make better effective antiemetic regimen. The article focuses on radiation therapy induced nausea and vomiting along with their mechanism of action and treatment strategies in order to have a remarkable patient care.

AYURVEDIC MANAGEMENT OF GARBHINI CHARDI (Emesis Gravidarum) WITH CHATURJATA CHOORNA (CHATURJATA POWDER) - A PILOT STUDY

2020 ◽  
Vol 8 (9) ◽  
pp. 4317-4323
Author(s):  
Priyanka 1 ◽  
Shreyes. S ◽  
Yogitha Bali M.R
Keyword(s):  
Pilot Study ◽  
Pregnant Women ◽  
First Trimester ◽  
Nausea And Vomiting ◽  
Morning Sickness ◽  
Excessive Salivation ◽  
First Trimester Of Pregnancy ◽  
Rice Water ◽  
Single Blind

Background: During pregnancy many demands are made by growing fetus, to meet these requirements maternal system has to undergo certain changes. Garbhinichardi (Emesis Gravidarum) is one among them and this has been termed as Gruhita Garbha Lakshanas (Immediate signs of conception) in Ayurvedic clas-sics. Approximately 80 % of pregnant women experience excessive salivation, nausea and vomiting during pregnancy, commonly known as “morning sickness”, which is seen frequently throughout the day. Design: This is single blind pilot study. 30 patients with complaints of Garbhinichardi (Emesis Gravidarum) in first trimester were included in this study. Patients were given Chaturjatachurna (Chatutjata powder)for a peri-od of 2 weeks in dose of 3gms thrice a day after meal with Anupana (Adjuvant) as Madhu (honey) of 5ml mixed with Tandulodaka (Raw rice water) Results: This pilot study showed statistically significant changes with Chaturjatachurna in reducing the complaints of pregnant women such as nausea (p<0.001), vomiting (p<0.001) and Aruchi (Anorexia) (p<0.001) in their first trimester of pregnancy. Conclusion: Chaturjata-churna was effective in the management of Garbhini Chardi (Emesis Gravidarum) and other symptoms in the first trimester of pregnancy.

Effect of remifentanil on postoperative nausea and vomiting: a randomized pilot study

2018 ◽  
Vol 32 (5) ◽  
pp. 781-785 ◽  
Author(s):  
Tatsunori Watanabe ◽  
Koji Moriya ◽  
Naoto Tsubokawa ◽  
Hiroshi Baba
Keyword(s):  
Pilot Study ◽  
Postoperative Nausea ◽  
Postoperative Nausea And Vomiting ◽  
Nausea And Vomiting
Sign in / Sign up

Export Citation Format

Share Document